Avac Event
Researchers broke down the recent case of HIV cure, the first among women. Speakers also provided updates from an ongoing trial studying pediatric remission. Participants learned what these advances mean for science and for people living with HIV.
Featuring:
Watch the recording:
Avac Event
On Wednesday, April 27, the CROI Community Liaison Subcommittee, AVAC, and European AIDS Treatment Group (EATG) held a webinar to debrief this year’s Conference on Retroviruses and Opportunistic Infections. Following a brief overview of some of the most notable science presented at CROI 2022, a panel of community discussants from around the world unpacked findings from the conference, shared perspectives, and offered advocacy suggestions. Topics will spanned science presented on HIV prevention and treatment, HIV and aging, HIV cure, and COVID-19 — among others.
Recorded CROI 2022 sessions are available to all on demand. Recordings from the series of research updates held during CROI — Margarita Breakfast Clubs — are available here.
The webinar discussants were:
Avac Event
On April 12, AVAC and FP2030 convened a consultation with family planning (FP) and sexual and reproductive health (SRH) stakeholders to understand their unique perspectives on the Dual Prevention Pill (DPP), a daily pill that prevents HIV and pregnancy. The consultation focused on key issues that must inform plans for DPP introduction plans and the development and delivery of future multi-purpose prevention technologies (MPTs).
Watch the recording (English, French) / Read the summary (English, French) / View the slides.
Avac Event
This year marks the 25th anniversary of HIV Vaccine Awareness Day. Nothing about HIV vaccine research has ever been easy, and this past year has shown us how difficult this research is, and how essential it continues to be.
Join us for a webinar series this month to mark important milestones in HIV vaccine development and discuss the path forward. The series is chaired by Bill Snow and Stacey Hannah and offers expert perspective on three angles that are critical to vaccine development: Platforms, Processes and Prospects.
Platforms & Pipelines
Wednesday May 18, 2022
The miracle of mRNA: What’s possible beyond SARS-CoV-2—understanding mRNA, its history and potential challenges for HIV vaccines. With Bart Haynes (Duke), Nina Russel (Bill & Melinda Gates Foundation) and Ntando Yola (DTHF).
Recording and Slides: YouTube / Nina Russell’s Slides / Bart Haynes’ Slides
Processes
Tuesday May 24, 2022
The changed landscape of clinical research: the potential for experimental medicine vaccine trials in the current research environment. With Gail Broder (HVTN), Pontiano Kaleebu (MRC-UK) and Robin Shattock (Imperial College).
Recording and Slides: YouTube / Robin Shattock’s Slides / Gail Broder’s Slides / Pontiano Kaleebu’s Slides
Prospects
Tuesday May 31, 2022 @ 10.00am EDT
What have we learned, why it matters and what it means? Understanding recent results in HIV vaccine research and implications for the future. Unpacking results from Uhambo and Imbokodo trials and understanding the implications for the current pipeline of products. With Galit Alter (Harvard), William Kilembe (ZEHRP), Ethel Makila (IAVI) and Dale Hu (NIH).
Recording: YouTube
Avac Event
On Tuesday, May 24, 2022, AVAC and partners held Processes, the second webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the changed landscape of clinical research and the potential for experimental medicine vaccine trials in the current research environment.
Recording and Slides: YouTube / Robin Shattock’s Slides / Gail Broder’s Slides / Pontiano Kaleebu’s Slides
Avac Event
On Tuesday, May 31, AVAC and partners held Prospects, the third webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the what we have learned, why it matters and what it means. They looked at recent results in HIV vaccine research and implications for the future, unpacked results from Uhambo and Imbokodo trials and talked about the implications for the current pipeline of products.
Avac Event
On Wednesday, May 18, 2022, AVAC and partners held Platforms & Pipelines, the first webinar in our HVAD 2022 webinar series. The moderators and panelists will discussed the miracle of mRNA—its history and potential challenges for HIV vaccines and what’s possible beyond SARS-CoV-2.
Recording and Slides: YouTube / Nina Russell’s Slides / Bart Haynes’ Slides
Avac Event
With Dominika Seidman, University of California San Francisco. For more details on The Choice Agenda and information on other calls, visit avac.org/choice-agenda.
Avac Event
Featuring Anne Philpott, Joao Alves, and Christine Curley. For more details on The Choice Agenda and information on other calls, visit avac.org/choice-agenda.
Avac Event
Following the World Bank Directors on June 30th, this webinar moderated by GFAN Director Katy Kydd Wright and co-hosted by AVAC, Equal, Friends of the Global Fight, Frontline AIDS and the Joep Lange Institute; we will: